Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome

NCT02484924 is registered in ClinicalTrials.gov with Liverpool University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT02484924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02484924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
Lead sponsor
Liverpool University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2016
Enrollment
5,225 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, bleeding, clopidogrel, novel anti-platelets, ticagrelor